key: cord-0280905-cdevm4eq
authors: Smith, A. E.; Wade, A. T.; Olds, T. S.; Dumuid, D.; Breakspear, M.; Laver, K. E.; Goldsworthy, M. R.; Ridding, M. C.; Fabiani, M.; Dorrian, J.; Hunter, M.; Paton, B.; Abdolhoseini, M.; Aziz, F.; Mellow, M. L.; Collins, C. E.; Murphy, K.; Gratton, G.; Keage, H. A.; Smith, R. T.; Karayanidis, F.
title: Optimising activity and diet compositions for dementia prevention: Protocol for the ACTIVate prospective longitudinal cohort study
date: 2021-07-31
journal: nan
DOI: 10.1101/2021.07.28.21261299
sha: 8e3d06ad5dbcf29719eb579bcce75ea993998018
doc_id: 280905
cord_uid: cdevm4eq

Introduction Approximately 40% of late-life dementia may be prevented by addressing modifiable risk factors, including physical activity and diet. Yet, it is currently unknown how multiple lifestyle factors interact to influence cognition. The ACTIVate Study aims to 1) Explore associations between 24-hour time-use and diet compositions with changes in cognition and brain function; and 2) Identify durations of time-use behaviours and the dietary compositions to optimise cognition and brain function. Methods and analysis This three-year prospective longitudinal cohort study will recruit 448 adults aged 60-70 years across Adelaide and Newcastle, Australia. Time-use data will be collected through wrist-worn activity monitors and the Multimedia Activity Recall for Children and Adults (MARCA). Dietary intake will be assessed using the Australian Eating Survey food frequency questionnaire. The primary outcome will be cognitive function, assessed using the Addenbrooke's Cognitive Examination-III (ACE-III). Secondary outcomes include structural and functional brain measures using Magnetic Resonance Imaging (MRI), cerebral arterial pulse measured with Diffuse Optical Tomography (Pulse-DOT), neuroplasticity using simultaneous Transcranial Magnetic Stimulation (TMS) and Electroencephalography (EEG), and electrophysiological markers of cognitive control using event-related potential (ERP) and time-frequency analyses. Compositional data analysis, testing for interactions between time-point and compositions, will assess longitudinal associations between dependent (cognition, brain function) and independent (time-use and diet compositions) variables. Conclusions The ACTIVate Study will be the first to examine associations between time-use and diet compositions, cognition and brain function. Our findings will inform new avenues for multidomain interventions that may more effectively account for the co-dependence between activity and diet behaviours for dementia prevention. Ethics and dissemination Ethics approval has been obtained from University of South Australia's Human Research Ethics committee (202639). Findings will be disseminated through peer reviewed manuscripts, conference presentations, targeted media releases and community engagement events. Registration Details: Australia New Zealand Clinical Trials Registry (ACTRN12619001659190).

Dementia is one of the leading causes of death and disability in older adults [1, 2] . As the 48 population ages, rates of dementia are expected to increase substantially. Worldwide, it was 49 estimated that 46.8 million people were living with dementia in 2015 [3] . By 2050, this number is 50 predicted to triple to 131.5 million [3] . In the absence of effective pharmacological treatments, and 51 with up to 40% of late life dementia attributed to modifiable risk factors [4] , prevention has moved 52 to the forefront of dementia research. 53

Lifestyle factors such as physical activity, sedentary time, sleep and dietary intake are known 55 modifiable risk factors for dementia [5] [6] [7] [8] . These factors have typically been researched as 56 independent predictors of dementia risk and are either targeted separately in intervention studies 57 or clustered together in multi-domain trials with little consideration of how they interact [9] . 58 However, lifestyle factors are not independent of each other. In fact, physical activity, sedentary 59 time and sleep are, by nature, co-dependent and constitute mutually exclusive and exhaustive parts 60 of a 24-hour day. If time spent in one of these behaviours increases, time in other(s) must decrease 61 to compensate. Time spent in these behaviours is also likely to be linked with dietary intake (for 62 example, more time spent in front of television is associated with more snacking). In fact, dietary 63 intake itself can also be conceptualised as a composition of distinct food groups which are co-64 dependent on each other [10] . That is, increased consumption of one food or food group may lead 65 to relative compensatory changes across other foods or food groups. Thus, time-use behaviours 66 and dietary intake should be considered as interrelated compositional predictors of dementia risk. 67

To more fully understand their role in dementia prevention and to better design interventions, it is 68 necessary to both characterise and account for their co-dependency. 69 Although it makes sense to consider all daily time-use behaviours and all dietary components 70 together, epidemiologists have largely been unable to include them in the same analytical model 71 due to the perfect multi-collinearity between parts of such compositions. Recently, an analytical 72 approach specifically designed for the analysis of compositions, named compositional data 73 analysis (CoDA) [11] , has been applied to overcome the multi-collinearity issue of time-use [5, 6] 74 and diet [12] composition data, and to enable the inclusion of all components in the same statistical 75 model. CoDA expresses time spent in different activities or proportions of food groups as isometric 76

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint log ratios, which can then be used as variables in standard statistical analyses. CoDA can also 77 consider sub-compositions, subsets of the activity or diet composition (for example, waking hours, 78 or vegetable intake). In these models, an extra term may be included in the regression representing 79 the sub-compositional total (e.g., the total number of waking hours, or the total number of serves 80 from vegetables). These analyses will tell us whether the mix of activities or dietary components 81 in the sub-composition, independent of the total, is associated with some outcome. 82

A recent application of CoDA, called compositional isotemporal substitution, [13] proportions of macronutrients, micronutrients and food groups are associated with waist 89 circumference, plasma lipids and lipoproteins, and glucose concentrations [10, 14] . Just as 90 isotemporal substitution models the effects of time reallocations, isocaloric substitution can be 91 used to model the effects of dietary reallocations while accounting for variance in total caloric 92 intake. 93

It is well accepted that structural and functional brain changes begin manifesting asymptomatically 95 years before dementia is diagnosed [15] [16] [17] . These changes may include accelerated brain atrophy 96 [15] , accumulation of protein aggregate in the brain [18] , disrupted integrity of the cerebrovascular 97 system [19] , and failure of the brain to undergo plastic re-organisation, otherwise referred to as 98 neuroplasticity [20] . Imaging techniques that characterise brain structure and function (Magnetic 99

Resonance Imaging, MRI), map brain temporal dynamics (Electroencephalography, EEG), and 100 measure cerebral arterial pulse (Diffuse Optical Tomography, Pulse-DOT) [21, 22] , as well as non-101 invasive brain stimulation techniques (repetitive Transcranial Magnetic Stimulation, TMS) are 102 now at the forefront of identifying and tracking pre-clinical brain changes in dementia research [9, 103 23, 24] . 104

Aims 105 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint

The ACTIVate Study will explore how daily time-use and diet compositions are associated with 106 cognition to inform dementia prevention. Iterative analyses of different activity and diet 107 compositions will be used to identify "best days" -optimal combinations of activities and food 108 groups associated with the greatest possible reduction in dementia risk. Together, these analyses 109 will inform the co-design of an interactive tool that will estimate the predicted change in cognition 110 for changes in time-use and/or dietary behaviour. 111

The ACTIVate Study will also include a secondary mechanistic focus, tracking brain structure and 112 function longitudinally. This novel approach will enable us to model the benefits of modifying 113 either time use or diet, or both concurrently. By tracking secondary imaging and 114 neurophysiological measures longitudinally alongside traditional cognitive assessments, we 115 expect to be able to detect subtle brain changes that may occur before behavioural differences 116 become apparent. 117

Using longitudinal data collected from older adults over a period of three years, the ACTIVate 118 Study will aim to: 119 1. Explore how 24-hour time use and diet compositions are associated with changes in 120 cognition and brain function; 121 2. Identify the best durations of time-use behaviours and the best proportions and 122 compositions of food groups to optimise cognition and brain function. 123 [25] . 149

Using a rolling convenience sampling strategy, all participants will be enrolled over an 18-month 150 period. Paper, radio and electronic advertisements will be disseminated across the Adelaide greater 151 metropolitan area and the Hunter Region. Existing volunteer databases will also be utilised. 152

Volunteers will first undergo a phone screening interview, during which the MoCA-B will be 153 administered to screen against dementia. Screening for other exclusion criteria will also be 154 completed. Volunteers who meet all eligibility criteria will be invited to participate and scheduled 155 for Baseline assessments. To ensure similar inclusion/exclusion criteria are adhered to at both 156 study sites a weekly eligibility meeting will be conducted to discuss any potential cases with an 157 eligibility query. Study. The ACE-III is a brief cognitive screening tool that demonstrates high internal reliability 162 (Cronbachs α = 0.88), as well as high sensitivity (1.00) and specificity (0.96) for the detection of 163 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint dementia using the cut-off score of 88/100 [26] . For the purpose of the ACTIVate Study, the ACE-164 III score will be assessed as a continuous variable. The ACE-III assesses function across five 165 cognitive domains: memory, attention/orientation, fluency, language and visuospatial. Our pilot 166 data also indicate that the ACE-III is sensitive to intra-individual differences in daily activity 167 patterns. To control for possible practice effects, all three Australian versions of the ACE-III will 168 be used, with Version A administered at Baseline, Version B at 18 months and Version C at 36 169 months. 170

Daily time-use composition 172

Time-use data will be captured objectively using 24-hour 7-day accelerometry with Axivity AX3 173 wrist-worn triaxial devices. Triaxial accelerometers measure acceleration along three planes 174 (vertical, anteroposterior and mediolateral) and have high predictive validity for physical activity 175 intensity [27] . The AX3 has demonstrated a high level of accuracy in detecting and classifying 176 time spent in physical activity [5] and has been validated for use in older adults [28] . Wrist-worn 177 AX3 monitors have been chosen over lower limb-mounted devices due to evidence of higher levels 178 of wear time compliance across a 24-hour period [29] . 179

While wearing the AX3, participants will be asked to maintain a self-report record of sleep and 180 wake times and to detail any periods of removal. Raw accelerations will be condensed into 60-s 181 data epochs and categorised into either time spent in sedentary behaviour, light physical activity, 182 moderate physical activity or vigorous physical activity, using pre-defined cut-points (46/93/418 183 for light, moderate and Vigorous physical activity, respectively) adjusted for 100 Hz sampling 184 frequency [30, 31] . Sleep duration and disturbances will be classified using an algorithm developed 185 by van Hees et al. [32] , in conjunction with self-report record of non-wear, sleep and wake times. 186

Self-reported time-use data will be collected using the Multimedia Activity Recall for Children 187 and Adults (MARCA). The MARCA is a computerised time-use recall tool containing over 500 188 activities linked to an energy expenditure compendium [33] . When completing the MARCA, 189 participants will be asked to recall every activity they engaged in over the previous two days in minute increments. Activity categories include 'Passive Transport', 'Sports and recreation ', 191 'Work', 'Self-Care', 'Household Chores' and 'Screen Time'. The MARCA has strong validity 192 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint when compared to accelerometry data in adults (rho=0.72), and excellent test-retest reliability 193 (ICC: 0.99 -1.00) [34] . 194

Diet composition will be operationalised as serves per day, between and within five food groups: 196 1) Fruits and vegetables; 2) Protein; 3) Fats 4) Cereals; 5) Discretionary foods. In the first step, we 197 will determine the optimal proportion of each food group as part of the whole diet. The second 198 step will identify the optimal composition of each food group. The compositions of each food 199 group are presented in Table 1 , and are informed by the Australian Dietary Guidelines [35] and 200 previously published associations between dietary intake, cognitive function and dementia risk 201 [36] [37] [38] [39] . 202

Dietary intake will be measured using the Australian Eating Survey, a 120-item semi-quantitative 203 food frequency questionnaire designed to capture the nutrient intake of Australian adults against a 204 contemporary list of foods that represent the current Australian food supply [40] . Participants will 205 be asked to report how frequently they consume different foods and food types over the past 6 206 months, with responses ranging from 'Never' to 4 or more times per day', with some beverages 207 up to '7 or more glasses per day'. Foods are organised into the following categories: drinks, breads 208 and cereals, dairy food, main meals, sweets and snacks, fruit and vegetables. The Australian Eating 209

Survey provides accurate estimates of nutrient intake for macro-and micronutrients which have 210 been validated against 4-day weighed food records [40] , as well as plasma carotenoids for fruit 211 and vegetable intake [41] and erythrocyte fatty acids [42] . 212

Consumption of oils, such as extra virgin olive oil, have been associated with reduced risk of 213 cardiovascular disease and cognitive decline, and are therefore of interest to the current study [21-214 23] . To estimate oil intake, an additional dietary questionnaire will be administered. The structure 215 of the dietary oils questionnaire is based on the polyunsaturated fatty acids questionnaire 216 developed by Swierk et al [43] . Participants will be asked whether they consume different dietary 217 oils and fats, including butter, butter blends, margarine, margarine blends, lard, vegetable oil, 218 canola oil, sunflower oil, coconut oil and olive oil. If participants respond 'Yes', they are prompted 219 to indicate how much of each oil they usually consume each day, ranging from 'Less than ½ a 220 tablespoon' to '8 or more tablespoons'. 221 222 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint The MRI protocol will include T1-weighted structural scan, T2 FLAIR, diffusion weighted 227 imaging (dMRI) and resting-state functional MRI (rs-fMRI) and associated field maps ( Table 2) . 228 T1-weighted images will be used for co-registration of dMRI, rs-fMRI and optical imaging data, 229 individual targeting of the prefrontal cortex with TMS, as well as morphometric analysis of white 230 and grey matter volume and parcellation of different brain area volumes. T2 FLAIR will enable 231 the analysis of deep white matter hyperintensities, combining with the T1 weighted images to 232 create artificial myelin burden contrasts. dMRI will be used to derive white matter tract structural 233 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint connectivity and rs-fMRI for analysis of functional connectivity. MRI scans will be collected on a 234

Siemens Skyra 3T scanner in Adelaide and a Siemens Prisma 3T scanner in Newcastle, both using 235 a 64-channel head and neck coil. MRI protocols have been calibrated across sites to ensure 236 comparable data quality given the differences in the gradient systems and capabilities of the two 237 different scanners. 238 239 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint Concurrent TMS and EEG (TMS-EEG) and repetitive TMS will be used at the Adelaide site to 243 investigate the secondary mechanism of prefrontal neuroplasticity [44] , at Baseline and 3-years. 244

Participants will complete two sessions (at least 7 days apart), each consisting of a ~2-hour TMS-245 EEG protocol. EEG will be recorded at rest and while stimulating the cortex to assess 246 neuroplasticity. Single-pulse TMS will be applied using a hand-held figure-of-eight magnetic coil 247 connected to a Magstim 200 stimulator (Magstim, Whitland, UK). A neuro-navigation system 248 (ANTneuro visor2) loaded with individual structural MRIs will be used to localise the left superior 249 frontal gyrus (SFG). Additionally, the neuro-navigation software will be used to calculate coil-to-250 cortex distance of the motor cortex and SFG. Continuous theta-burst stimulation (cTBS) will be 251 delivered at 70% resting motor threshold, adjusted for the difference between coil-to-cortex 252 distance between the motor hotspot and SFG [45] . To experimentally-induce neuroplasticity, an 253 inhibitory repetitive TMS paradigm, cTBS (real or sham, with session order randomised), will be 254 applied for 40 seconds to the left SFG. Changes in SFG excitability from pre to post cTBS will 255 be quantified as changes in the amplitude of TMS-evoked potentials (TEPs) in the EEG signal. 256

TEPs will also be recorded for an equivalent amount of single-pulse TMS stimulations to the left 257 shoulder before and after cTBS, in order to measure peripherally-evoked potentials and minimise 258 the contribution of sensory artifacts to TEPs [46] . Participants will be instructed to sit quietly, keep 259 their eyes open, and look straight ahead during each TMS-EEG recording period, and a masking 260 noise will be applied through earphones (< 70 dB in each ear) to minimise contamination of the 261 EEG by the audible click of the TMS discharge. 262

Diffusion Optical Tomographic (DOT) imaging: Newcastle site only 263

Cerebral arteries and arterioles become less able to flexibly contract and dilate with changing 264 metabolic demands and challenges (i.e., cerebrovascular reactivity) and their walls become stiffer 265 (i.e., arteriosclerosis or reduced arterial elasticity). This is particularly evident in the prefrontal 266 cortex (PFC) [22] , which supports cognitive control processes. Reduced reactivity and elasticity 267 of the brain's arteries are associated with structural changes in the corresponding cortex [23] and 268 decline in associated cognitive abilities [47] . Pulse-DOT (cerebral arterial pulse measured with 269 diffuse optical tomography) provides a direct measure of the regional reactivity and elasticity of 270 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint cerebral arteries with high spatial resolution (by co-registration to individual anatomical MRI 271 scan). 272

Cerebral arterial elasticity and arterial reactivity will be measured at the Newcastle site using non-273 invasive pulse-DOT and fNIRS measures recorded with an ISS Imagent device. Three montages 274 (with four detectors and 32 sources each) will be used to cover the participant's prefrontal cortex 275 using a custom-made foam cap with 2 min recording per montage. The location of possible fibre 276 positions across the scalp and fiducial points will be digitized (Polhemus 3D) to allow 277 detector/source locations to be co-registered to the participant's T1 anatomical MRI image. EKG 278 (500 Hz, 1-100 Hz bandpass filter) will be used to identify the R wave and synchronise recording 279 montages and locations. Pre-processing of the AC-intensity data will use measures established 280 previously [27, 28] . We will record at rest to derive pulse relaxation function (PReFx), a regional 281 measure of arterial elasticity which is sensitive to the status of cortical arteries whose downstream 282 branches perfuse periventricular areas, where white matter hyperintensities are most common. We 283 will also measure cerebrovascular reactivity by recording during a Breath Holding Task (BHT). 284 which induces hypercapnia in the brain [48, 49] Changes in optical pulse amplitude will be 285 obtained during difference phases of the BHT, to assess reactivity to the hypercapnia challenge, 286 using parameters and trial structure previously established [50] . 287

Secondary cognitive outcomes 289

Neuropsychological assessments. The Cambridge Neuropsychological Test Automated Battery 290 (CANTAB) will be administered to assess executive function, memory and processing speed 291 domains that are known to be sensitive to age-related cognitive decline and dementia [7, 51] . 292

Previous studies have demonstrated that these cognitive domains can be influenced by lifestyle 293 factors such as physical activity and diet [52] [53] [54] [55] ORR, and Picture Vocabulary (PV), will be administered to assess language. A summary of 298 cognitive assessments is presented in Table 3 . 299 300 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. The ACE-III is a pen and paper-based test administered by trained study personnel. Participants are asked to recall the date, season and current location; repeat back and remember three simple words; conduct serial subtraction; memorise and recall a fictional address; recall widely known historical facts; recall as many words beginning with a certain letter in one minute; recall as many animals as they can think of in one minute; follow a sequence of physical commands; write two grammatically correct sentences; repeat four polysyllabic words and two short proverbs; identify 12 objects shown in line drawings; read aloud five commonly mispronounced words; copy two diagrams; draw a clock; count four sets of dots and recognise four letters that are partially obscured. The participant is instructed to touch the centre of a flashing cross that appears across the screen in different locations.

Paired Associates Learning (PAL)

Boxes are displayed on the screen and open in a randomised order. One or more boxes will contain a pattern. The patterns are then displayed in the middle of the screen, one at a time and the participant is instructed to select the box in which the pattern was originally located. If the participant makes an error, the boxes are opened in sequence again to remind the participant of the locations of the patterns. In the first phase, a sequence of words is displayed on the screen one at a time. The participant is then instructed to recall as many words as they can remember. In the second phase, two words are displayed on the screen. The participant is instructed to choose the word they remember from the previous list.

One Touch Stockings of Cambridge (OTS)

Executive function -spatial planning and working memory

The screen is divided into two halves, each of which contains a display of three coloured balls arranged across three 'stockings'. The participant is asked to determine the minimum number of moves required to match the position of balls in lower display to the upper display, moving only one ball at a time.

Processing speed -motor speed, response speed and accuracy

A yellow spot appears in the centre of the screen and the participant is instructed to touch the spot as fast as possible. In the 'Simple' stage, the spot will appear in only one location for 10 trials. In the 'Choice' stage, the spot will appear in one of five locations for 15 trials.

Executive function -attentional set shifting Arrows appear on each side of the screen and the participant is cued to indicate either the direction that the arrow is pointing, or the side of the screen on which the arrow appears.

Verbal memory and learning

The second phase of VRM described above is repeated after a period of 20 minutes.

Languagereading and decoding skills A word is presented on the screen, one at a time.

Participants are asked to read and pronounce each word as accurately as possible.

Picture Vocabulary (PV)

A word is read aloud while four images are displayed on the screen. Respondents are instructed to select picture that most closely matches the meaning of the word.

Behavioural and event-related potential (ERP) measures of cognitive control. Participants will 303 complete a cued-trial task-switching paradigm while we record their electroencephalogram (EEG) 304 to assess proactive cognitive control processes [56] . Participants will complete two choice reaction 305 time tasks (letter and number classification) using colour cues that are mapped to each task [57] . 306

The cue validly indicates whether the letter or the number task will be performed on the upcoming 307 target, allowing the participant to upload the task, but not activate a response until after target onset 308 (cue-target interval 1000 ms). EEG will be recorded using a 64-channel system (ANT in Adelaide; 309 BioSemi in Newcastle) while participants complete either each task alone (single-task blocks) or 310 switch between the two tasks using a random cue colour sequence (mixed-task blocks). 311

Two indices of task-switching performance are derived: switch cost (switch -repeat trials in a 312 mixed-task block) represents the cost of updating task-set on switch trials, whereas mixing cost 313 (repeat trials in a mixed-task vs. a single-task block) represents the additional working memory 314 load of maintaining two or more representations accessible in mixed-task blocks [58, 59] . 315

Increasing age across the adult lifespan is associated with a robust mixing cost, but a less consistent 316 effect on switch cost [60, 61] . Cue-locked ERP analyses show two parietally-maximal difference 317 components: switch-positivity is associated with preparing to shift task-set, whereas mixing-318 positivity is associated with working memory load. Both positivities vary in amplitude and scalp 319 distribution across the adult lifespan, with age effects on ERPs emerging much earlier than effects 320 on behavioural indices of task-switching [60] . In mid-late life, mixing cost is associated with 321 reduced microstructural integrity of fronto-parietal white matter tracts (ie., superior longitudinal 322 fasciculus, inferior fronto-opercular tract) [62] . Task switching ability has also been shown to be 323 sensitive to variability in physical activity and nutrition [63, 64] . 324

Hypertension is a known modifiable risk factor for dementia [65] . Blood pressure will be assessed 326 using an OMRON Healthcare Co. digital blood pressure monitor (model 1A1B Hem-7000-CIL). 327

Participants will be seated for at least 5 minutes. Three measurements of blood pressure will be 328 taken, each spaced at least one minute apart, with the forearm rested at table height and the cuff 329 will be placed approximately 2-3 cm above the anti-cubital fossa. Both, average values for systolic 330 blood pressure, diastolic blood pressure and heart rate and difference between systolic and diastolic 331 pressure will be calculated. 332 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint

Fasting venous blood will be drawn by venepuncture by a trained phlebotomist to measure lipids 334 profiles, glucose, inflammatory markers, erythrocyte fatty acids and genetic risk profiles. A total 335 of 60 mL will be collected, centrifuged (4°C, 4000 rpm, 10 minutes) and frozen at -80°C for batch 336 processing at the end of each data collection timepoint. Blood samples will be analysed in duplicate 337 with commercial assay kits (including quality controls and calibrators) using the KONELAB 338 20XTi (ThermoFisher, Massachusetts, United States). 339

Alzheimer's Disease risk 340

The ANU Alzheimer's Disease Risk Index (ANU-ADRI) will be administered to calculate risk of 341

Alzheimer's disease. The ANU-ADRI is an evidence-based self-report measure of exposure to risk 342 and protective factors associated with Alzheimer's disease (AD), including age, sex, education, 343 body mass index, diabetes, depression, cholesterol, traumatic brain injury, smoking, alcohol 344 intake, social engagement, physical activity, cognitive activity, fish intake, and pesticide 345 exposure. The ANU-ADRI has high predictive validity for incident Alzheimer's disease and 346 dementia [66] . 347

Subjective memory complaints and self-reported cognitive change are strong predictors of 349 cognitive decline, even when performance on cognitive tests is unimpaired [67] . Therefore, the 350 Cognitive Function Instrument (CFI) will be administered to capture subjective cognitive decline. 351

The CFI is a 14-item self-report measure of change in daily functioning with reference to 352

functioning one year prior [68] . The CFI has demonstrated high test-retest reliability (ICC: 0.76 -353 0.78), and strong correlations with longitudinal Clinical Dementia Rating scores [68] . 354

As both objective and subjective measures of sleep are associated with increased risk of cognitive 356 decline and dementia [69] , subjective sleep quality will be captured using the Pittsburgh Sleep 357 Quality Index (PSQI). The PSQI is a self-report questionnaire that assesses sleep quality over is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint PSQI has demonstrated high validity when compared with objective measures of sleep quality and 361 disturbance and has high test-retest reliability [70] . 362

Quality of life will be assessed using the EuroQol-5 Dimension (EQ5-D) . The EQ-5D assesses 364

health-related quality of life across five dimensions: mobility, self-care, usual activities, 365 pain/discomfort and anxiety/depression. The EQ-5D has been validated for use in older 366 populations with cognitive impairment [71] . Further, it is widely used for the economic valuation 367 of health interventions and has Australian-based population norms [72] . 368

Covariates 369

Covariates will include education, socioeconomic status, comorbidities and medications, smoking 370 and alcohol use, body composition, hearing loss and Apolipoprotein E4 (ApoE4). 371

Education, smoking and alcohol use will be determined from the ANU-ADRI questionnaire [66] . 372

Comorbidities and medication use will be collected through interview questions informed by the 373 Australian Longitudinal Study of Ageing [73] . Participants will be asked to confirm current health 374 conditions, medications and supplements, including medication type, dose, duration of intake, and 375 whether the medication was prescribed by a doctor or health professional. 376 Body weight will be measured using an electronic scale with volunteers wearing minimal clothing 377 and without shoes. Height will be measured using a wall mounted stadiometer (SECA, Hamburg, 378

Germany) with volunteers in stockinged or bare feet. Waist and hip circumference (in centimetres) 379 will be measured according to the protocols of the International Society for the Advancement of 380

Kinathropometry and used to calculated waist to hip ratio [74] . 381

Hearing loss is a significant predictor of dementia [65] and will be captured using a short 382 questionnaire, previously described Amieva et al [75, 76] . Participants will be asked if they 383 currently wear hearing aids, and if they have experienced any hearing difficulties in the past 12 384 months. Self-reported hearing loss is highly correlated with audiometric measures [75] and is 385 associated with an increased risk of cognitive decline and dementia over a follow-up period of 25 386 years [75, 76] . 387

The ApoE4 allele is the strongest genetic risk factor for Alzheimer's disease [77] . APOE status 388 will be determined through genetic risk profiling of blood samples described above. 389 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint Procedure 390

Participants will attend assessment visits at Baseline, 18 months and 36 months. Written informed 391 consent will be obtained at the beginning of the Baseline visit at both study sites. All measures 392 will be collected at Baseline and 36 months. Only Session 1 measures will be collected at 18 393 months. Table 4 lists the measures collected at each session. Due to logistical differences, the order 394 of assessments may vary between Adelaide and Newcastle. 395 Table 4 . Schedule of assessments. Session 1, 2 and 3 will be completed at Baseline and 36 months. 397

Only Session 1 will be completed at 18 months. 

Primary characteristics of the sample will be presented as per STROBE guidelines [78] . 402

Compositional multi-level mixed effects models, testing for interactions between time-point 403 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint (Baseline, 18 months and 36 months) and compositions of time-use and diet will assess 404 longitudinal associations between dependent (cognition, brain function and structure) and 405 independent (time-use and diet compositions) variables. If significant at p<0.05, interaction terms 406 will be included between the sets of time-use and diet composition log-ratios. Fixed effects will 407 include the time-use and diet compositions (each expressed as a set of isometric log ratios) and 408 covariates. Dietary analyses will also include total energy intake. Random intercepts will account 409 for repeated measures within a person, nested within study sites. A hierarchical nested model Identifying best days for cognition and brain health 417

Using iterative application of the compositional isotemporal substitution analyses, we will 418 generate n-dimensional heat maps or response surfaces for within-person change in activity and 419 diet composition and change in outcomes between sets of two time points (consecutive and distal), 420 adjusted for covariates. The highest regions of the response surfaces will correspond to the most 421 beneficial changes for improvement. These "peaks" or contours (e.g., corresponding to best 5% of 422 outcomes) will be expressed in terms of deviations from a reference time-use or diet composition, 423 to provide customised meaningful interpretation in min/d or servings of food groups. 424

In the absence of longitudinal data on diet and activity compositions in relation to cognitive 426 outcomes, we powered the ACTIVate study based on cross-sectional pilot data (age: 65 ± 7.6 y, 427 n=83) of a four-part time-use composition associated with ACE-III scores. Multiple regression 428 analyses gave an R 2 value of 0.20 when including covariates age and sex and compositional 429 variables for activity. We base our power calculation on these results, and assuming three 430 compositional parameters representing a four-part time-use composition (sleep, sedentary time, 431 light physical activity, and moderate-to-vigorous physical activity), and assuming 7 parameters for 432 the covariates (including four compositional parameters for a five-part diet composition). Aiming 433 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint for 80% power, alpha will be adjusted to 0.01 to account for multiple comparisons. Based on these 434 assumptions, the R package pwr [79] estimates a total sample size of 236 is needed for a general 435 linear model. This number is further inflated to account for the longitudinal design, allowing for 436 25% attrition over the 36-month period, and a 70% response rate at recruitment, resulting in a final 437 sample size of 448 adults at study enrolment (224 per site). 438

All data collected during this study, including informed consent, will be managed using REDCap 440 electronic data capture tools hosted at the University of South Australia. REDCap is a secure, web-441 based software platform designed to support data capture for research [80, 81] . Where data files 442 are too large to be uploaded to REDCap, files will be stored on a secure online data storage 443 platform hosted at the University of South Australia. Only listed investigators will have access to 444 the data. 445

There are small risks associated with the MRI and TMS non-invasive brain stimulation paradigms 447 for individuals with metal in their head or body and people with a history of epilepsy. To minimise 448 these risks, all participants will be required to complete an MRI and TMS safety screen. 449

Interested participants will provide written informed consent at study enrolment and verbally re-451 consent at 18 months and 3 years. If a participant is clinically diagnosed with dementia or develops 452 a disability affecting their ability to consent after Baseline assessments, a study partner will be 453 required and will be asked to provide written informed consent. Study information will still be 454 discussed with the participants and their chosen study partner, and if the participant decides they 455 no longer want to participate further, they will be withdrawn from the study. All participants are 456 free to withdraw from the study at any time with no consequence to them now or in the future. 457

The results of the ACTIVate study will contribute to multiple publications and will be presented 459 at several national and international conferences. Data will be published at multiple stages of the 460 study to ensure findings are communicated quickly and directly. 461 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07. 28.21261299 doi: medRxiv preprint In addition, the data for the primary dependent (cognition) and independent variables (diet and 462 activity composition) will be used in the development of a dementia prevention tool. 463

Full description of the co-design process involved in digital tool development is beyond the scope 465 of this protocol paper and will be published elsewhere. Briefly, using both the cross-sectional and 466 the longitudinal data collected, we will co-develop a tool with older adults that can be used by 467 older adults and clinicians for dementia prevention. All aspects of the tool interface will be co-468 designed through an iterative design process. The tool will provide customised suggestions on how 469 to improve time-use and dietary intake. Recommendations will be tailored to an individual's 470 situation, allowing the user to incorporate non-negotiable constraints on behaviours, for example, 471 long commute times to work. It will also consider constraints due to personal preference, for 472 example, preference to modify diet rather than time-use, or a desire to keep sleep duration constant 473 and modify waking activities only. 474

Once the ACTIVate study is complete, de-identified data will be made available to other research 476 groups upon reasonable request. To obtain an ethically compliant data set (with de-identified data) 477 researchers will contact the corresponding author and provide evidence of institutional ethics 478 approval for local data storage, analysis and security. 479

The ACTIVate study is the first of its kind to track time use, diet and cognition in older adults 481 across three successive years with the intention to use emerging statistical analysis techniques 482 (CoDA) to 1) Explore how changes in 24-hour time use and diet are associated with changes in 483 cognition and 2) Identify 'best days' for time use and dietary intake that optimise cognition. In 484 addition to the primary aims, each study site is leading an exploratory secondary biological 485 mechanism focus. We tentatively expect that these secondary mechanisms will provide sensitive 486 measures of variation in 'best day' compositions over time. A future aim of the ACTIVate study 487 is to use the data collected to co-create with older adults a fully customisable tool that can be 488 rapidly translated into primary care settings and be used for dementia prevention. 489

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint Data collection for the ACTIVate study was due to begin in March 2020. However, due to the 491 emergence of the novel coronavirus (COVID-19) as a global pandemic and the potential risk posed 492 to older participants, data collection has been postponed until it is deemed safe to continue. Data 493 collection procedures detailed within this paper may be modified to comply with emerging 494 COVID-safe protocols including minimising the time spent in close contact with participants. 495

Further, all investigators will undergo COVID specific training and participants and investigators 496 will wear personal protective equipment as required. 497

In the absence of effective pharmacological interventions that prevent dementia, current research 499 efforts are focussed on reducing dementia risk through modifiable lifestyle factors. Indeed, up to 500 40% of late life dementia is thought to be due to modifiable factors [4] . Further, population 501 estimates suggest that reducing the prevalence of each modifiable dementia risk factor by 10-20% 502 per decade would potentially reduce the worldwide prevalence of Alzheimer's disease (the most 503 common form of dementia) by between 8.8 and 16.2 million cases [82] . However, to our 504 knowledge, no studies have tracked time use, diet, cognition and brain function (using various 505 experimental neurophysiological techniques) longitudinally across time. Findings from this project 506 are likely to inform new avenues for multidomain interventions that accommodate the co-507 dependence between time use and diet behaviours for dementia prevention. Acknowledgements 519 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2021. ; https://doi.org/10.1101/2021.07.28.21261299 doi: medRxiv preprint

We thank Angela Walls and Shiami Luchow for their assistance setting up the Magnetic 520

Resonance Imaging (protocols) at SAHMRI and HMRI, respectively. 521 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 31, 2021. 

Australian Institute of Health and Welfare, Australia's Health

Alzheimer's Disease International

Alzheimer's Disease International, World Alzheimer's Report 2015: The global impact of dementia

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet

A comparison between three activity monitors in detecting commonly performed activities and postures of daily living

Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis

Promoting successful cognitive aging: a comprehensive review

Adherence to a Mediterranean-style diet can slow the rate of cognitive decline and decrease the risk of dementia: a systematic review

Building your best day for healthy brain aging-The neuroprotective effects of optimal time use

Compositional data analysis as an alternative paradigm for nutritional studies

The Statistical-Analysis of Compositional Data

Applying compositional data methodology to nutritional epidemiology

Compositional data analysis for physical activity, sedentary time and sleep research

A compositional data perspective on studying the associations between macronutrient balances and diseases

Structural MRI changes detectable up to ten years before clinical Alzheimer's disease

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study

Cerebrovascular assessment for the risk prediction of Alzheimer's disease

Plasticity in early Alzheimer's disease: An opportunity for intervention

Taking the pulse of aging: Mapping pulse pressure and elasticity in cerebral arteries with diffuse optical methods

Mapping Cerebral Pulse Pressure and Arterial Compliance over the Adult Lifespan with Optical Imaging

Individual differences in regional cortical volumes across the life span are associated with regional optical measures of arterial elasticity

Optical Measures of Cerebral Arterial Stiffness are Associated with White Matter Signal Abnormalities and Cognitive Performance in Normal Aging

Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research

Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease

Validity of estimating physical activity intensity using a triaxial accelerometer in healthy adults and older adults

Validation of the AX3 triaxial accelerometer in older functionally impaired people

Physical activity and incident cognitive impairment in elderly persons: the INVADE study

Evaluation of raw acceleration sedentary thresholds in children and adults

A Novel, Open Access Method to Assess Sleep Duration Using a Wrist-Worn Accelerometer

Development of a compendium of energy expenditures for youth

Development and evaluation of an adult useof-time instrument with an energy expenditure focus

Blueberry supplementation improves memory in older adults

MIND diet slows cognitive decline with aging

Virgin olive oil supplementation and long-term cognition: The PREDIMED-NAVARRA randomized trial. The Journal of Nutrition, Health and Ageing

Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial

Reproducibility and comparative validity of a food frequency questionnaire for Australian adults

Fruit and vegetable intake assessed by food frequency questionnaire and plasma carotenoids: a validation study in adults

Comparison of fatty acid intakes assessed by a cardiovascularspecific food frequency questionnaire with red blood cell membrane fatty acids in hyperlipidaemic Australian adults: a validation study

Validation of an Australian electronic food frequency questionnaire to measure polyunsaturated fatty acid intake. Nutrition

Age-related decline of neuroplasticity to intermittent theta burst stimulation of the lateral prefrontal cortex and its relationship with late-life memory performance

Distance-adjusted motor threshold for transcranial magnetic stimulation

Characterizing and minimizing the contribution of sensory inputs to TMS-evoked potentials

Striatal volume predicts level of video game skill acquisition

Assessing Cerebrovascular Reactivity in Carotid Steno-Occlusive Disease Using MRI BOLD and ASL Techniques

Reliable quantification of BOLD fMRI cerebrovascular reactivity despite poor breath-hold performance

Optical measures of changes in cerebral vascular tone during voluntary breath holding and a Sternberg memory task

Cognitive processing speed in older adults: relationship with white matter integrity

Exercise, ageing and cognitive function -Effects of a personalized physical exercise program in the cognitive function of older adults

A Mediterranean diet supplemented with dairy foods improves mood and processing speed in an Australian sample: results from the MedDairy randomized controlled trial

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

Exercise training increases size of hippocampus and improves memory

ERP measures of proactive and reactive control processes in task-switching paradigms, in Task switching and cognitive control

Age-related decline in task switching is linked to both global and tractspecific changes in white matter microstructure. Hum Brain Mapp

Control and interference in task switching: A review

Advance preparation in task-switching: converging evidence from behavioral, brain activation, and model-based approaches

Variability in proactive and reactive cognitive control processes across the adult lifespan

Reactive control processes contributing to residual switch cost and mixing cost across the adult lifespan

Age-related decline in task switching is linked to both global and tractspecific changes in white matter microstructure

The benefits of endurance exercise and Tai Chi Chuan for the taskswitching aspect of executive function in older adults: an ERP study. Front Aging Neurosci

Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial

Dementia prevention, intervention, and care. The Lancet

A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: the ANU-ADRI

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults

Impact of sleep on the risk of cognitive decline and dementia

The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments. Health Qual Life Outcomes

Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. Health Qual Life Outcomes

Cohort Profile: The Australian Longitudinal Study of Ageing (ALSA)

International standards for anthropometric assessment

Self-Reported Hearing Loss, Hearing Aids, and Cognitive Decline in Elderly Adults: A 25-Year Study

Death, Depression, Disability, and Dementia Associated With Selfreported Hearing Problems: A 25-Year Study

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

pwr: Basic Functions for Power Analysis

The REDCap consortium: Building an international community of software partners

A metadata-driven methodology and workflow process for providing translational research informatics support

Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. The Lancet Neurology